Comparison of insulin glargine 300 U/mL versus glargine 100 U/mL on glycemic control and hypoglycemic events in East Asian patients with type 2 diabetes: A Patient-level meta-analysis of phase 3 studies-Reference-Cited by-同舟云学术

Comparison of insulin glargine 300 U/mL versus glargine 100 U/mL on glycemic control and hypoglycemic events in East Asian patients with type 2 diabetes: A Patient-level meta-analysis of phase 3 studies

Published:2021-06 Issue: Volume:176 Page:108848
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Ji Linong,Bi Yan,Ye Shandong,Huang Yun,Zhang Xia,Shang Shuhua,Cui Nan,Yin Huiqiu,Zhang Minlu

Funder

Sanofi China

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference39 articles.

1. International Diabetes Federation - Facts & figures n.d. https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html (accessed November 15, 2019).

2. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes 2019 n.d.

3. Standards of medical care for type 2 diabetes in China 2019;Jia;Diabetes Metab Res Rev,2019

4. 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea;Kim;Diabetes Metab J,2019

5. Benefits of timely basal insulin control in patients with type 2 diabetes;Lovre;J Diabetes Complications,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Study on Effectiveness of Insulin Glargine U300 After Oral Antidiabetic Drug Failure in Patients with Type 2 Diabetes in the Gulf Region;Diabetes Therapy;2024-02-15

2. Clinical impact after implementing an insulin protocol involving a switch to insulin glargine 300 U/ml as basal insulin for inpatient glycaemic control: A retrospective single-centre study;Journal of Diabetes and its Complications;2023-09

3. Improved glycaemic control and weight benefit with iGlarLixi versus insulin glargine 100 U/ mL in Chinese people with type 2 diabetes advancing their therapy from basal insulin plus oral antihyperglycaemic drugs: Results from the LixiLan‐L‐CN randomized controlled trial;Diabetes, Obesity and Metabolism;2022-07-25

4. Evaluation of Patient Reported Satisfaction and Clinical Efficacy of Insulin Glargine 300 U/mL Versus 100 U/mL in Patients With Type 1 Diabetes Using Flash Glucose Monitoring System;Clinical Medicine Insights: Endocrinology and Diabetes;2022-01